Overview:

β-1,4-Galactosyltransferase 1, also known as B4GalT1, is one of seven β-1,4-Galactosyltransferases that transfer galactose to acceptor sugars, including GlcNAc , Glc , and Xyl . The Y285L single point mutation in B4GalT1 results in a switch in enzyme activity from Gal-transferase activity to GalNAc-transferase activity. Recombinant human B4GalT1 (Y285L) can be used to synthesize lacdiNAc -terminated glycoconjugates, which are terminal glycan modifications found on many glycoproteins, including the activating receptor for natural killer cells, NKR-P1, and CD69.

Reagent packaging:

Rhinogen ^® β-1,4-Galactosyltransferase 1 (Y285L) packaging specifications are as follows:

Note: The enzyme is supplied in liquid form in Tris and NaCl.

Product Features:

1. High purity: SDS-PAGE analysis, purity>90%;

2. High stability: Each batch of products undergoes strict quality control to achieve product batch-to-batch stability ;

3. High specificity: can specifically recognize fluorescent substrates.

Storage conditions:

Please store the product at -20~-70°C upon receipt. The shelf life is 6 months. After opening, store it at -20~-70°C for 3 months. Avoid repeated freezing and thawing.